As of 2025-07-03, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 7.84 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-06-26 | -8.72 |
| 2025-06-25 | -8.23 |
| 2025-06-24 | -8.16 |
| 2025-06-23 | -8.09 |
| 2025-06-20 | -8.24 |
| 2025-06-19 | -8.27 |
| 2025-06-18 | -7.98 |
| 2025-06-17 | -8.09 |
| 2025-06-16 | -7.79 |
| 2025-06-13 | -7.31 |
| 2025-06-12 | -7.30 |
| 2025-06-11 | -7.30 |
| 2025-06-10 | -7.45 |
| 2025-06-09 | -7.45 |
| 2025-06-06 | -7.26 |
| 2025-06-05 | -7.51 |
| 2025-06-04 | -7.40 |
| 2025-06-03 | -7.66 |
| 2025-06-02 | -7.36 |
| 2025-05-30 | -7.30 |
| 2025-05-29 | -7.40 |
| 2025-05-28 | -7.34 |
| 2025-05-27 | -7.26 |
| 2025-05-26 | -7.22 |
| 2025-05-23 | -7.19 |
| 2025-05-22 | -7.05 |
| 2025-05-21 | -7.20 |
| 2025-05-20 | -7.33 |
| 2025-05-16 | -7.31 |
| 2025-05-15 | -7.22 |
| 2025-05-14 | -7.23 |
| 2025-05-13 | -7.25 |
| 2025-05-12 | -7.29 |
| 2025-05-09 | -7.38 |
| 2025-05-08 | -7.27 |
| 2025-05-07 | -7.27 |
| 2025-05-06 | -7.57 |
| 2025-05-05 | -7.53 |
| 2025-05-02 | -7.53 |
| 2025-05-01 | -7.52 |
| 2025-04-30 | -7.51 |
| 2025-04-29 | -7.52 |
| 2025-04-28 | -7.59 |
| 2025-04-25 | -7.30 |
| 2025-04-24 | -7.51 |
| 2025-04-23 | -7.22 |
| 2025-04-22 | -7.22 |
| 2025-04-21 | -6.62 |
| 2025-04-17 | -6.23 |
| 2025-04-16 | -6.07 |